search
Back to results

Mental Health Specialist Video Consultations for Primary Care Patients (PROVIDE-C)

Primary Purpose

Depression, Anxiety Disorder

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
mental health specialist video consultation
Sponsored by
Heidelberg University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Depression focused on measuring primary care, mental health, telemedicine, video consultations, effectiveness, health services research

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • at least one of the following psychological conditions i) at least moderately severe depression, defined as a PHQ-9 score of 10 or greater with either item one and/or two being endorsed, ii) at least moderately general anxiety disorder, defined as a Generalized Anxiety Disorder (GAD)-7 score of 10 or greater, or iii) exceeding the cut off of 11 points of the combined anxiety and depression score (PHQ-ADS)
  • currently no or as yet insufficient treatment (psychotherapy, psychopharmacotherapy, or both) or difficulty with adherence
  • capable of giving consent
  • written informed consent

Exclusion Criteria:

  • substance abuse/dependence that is likely to compromise intervention adherence
  • risk of endangerment to others and/or risk of self-endangerment
  • need for emergency medical treatment
  • acute psychotic symptoms
  • severe cognitive impairment or dementia
  • significant hearing and/or visual impairment
  • pregnancy in the ≥ 2nd Trimester
  • prior experience with video consultations as part of the feasibility trial
  • insufficient German language proficiency

Sites / Locations

  • Heidelberg University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

mental health specialist video consultation

treatment as usual by the GP

Arm Description

The intervention group will receive five video consultations with psychotherapists directly in the GP's practice. The consultations will be carried out via the web portal of a certified video service provider (arztkonsultation ak GmbH). The patient will be located in the GP's practice and the psychotherapist in his practice or another suitable room. Patients are scheduled for five sessions of 50 minutes.

Routine treatment by the GP, which may or may not include conversations about psychosocial problems and/or referral to specialised services (e.g., inpatient therapy, counseling, self-help).

Outcomes

Primary Outcome Measures

The Patient Health Questionnaire Depression and Anxiety Scale (PHQ-ADS)
composite measure of depression and anxiety (range: 0-48 Points, higher score indicates more severly depressed/anxious)

Secondary Outcome Measures

The Patient Health Questionnaire Depression and Anxiety Scale (PHQ-ADS)
composite measure of depression and anxiety (range: 0-48 Points, higher score indicates more severly depressed/anxious)
The Patient Health Questionnaire (PHQ-9)
depressive symptom severity (range: 0-27 Points, higher score indicates more severly depressed)
Generalized Anxiety Disorder Scale (GAD-7)
anxiety symptom severity, range: 0-21, higher score indicates worse outcome
Short-Form Health Survey 12 (SF-12)
health related quality of life (two dimensions: physical and mental quality of life, ranges: 0-100, higher score indicates higher quality of life
Recovery Assessment Scale (RAS-G)
self-reported mental health recovery, five dimension: 1) Goal and success orientation, 2) No domination by Symptoms, 3) Personal confidence and hope, 4) Reliance on others, 5) Willingness to ask others for help, ranges 1-5, higher score indicates better outcome
Somatic Symptom Disorder-B Criteria Scale (SSD-12)
self-reported somatisation, range: 0-48, higher score indicates worse outcome
Patient Assessment of Chronic Illness Care (PACIC)
patients' satisfaction with the care of their chronic disease, range: 1-5, higher score indicates higher satisfaction
EQ-5D
health related quality of life for health economic Evaluations, 5 dimensions: 1) Mobility, 2) Self-Care, 3) Usual Activities, 4) Pain/Discomfort, 5)Anxiety/Depression
Questionnaire for the Assessment of Medical and non Medical Resource Utilisation in Mental Disorders (FIMPsy)
self reported use of medical and psychosocial services for health-economic evaluation

Full Information

First Posted
March 18, 2020
Last Updated
July 30, 2023
Sponsor
Heidelberg University
Collaborators
Heinrich-Heine University, Duesseldorf
search

1. Study Identification

Unique Protocol Identification Number
NCT04316572
Brief Title
Mental Health Specialist Video Consultations for Primary Care Patients
Acronym
PROVIDE-C
Official Title
ImPROving Cross-sectoral Collaboration Between Primary and Psychosocial Care: A Randomised Controlled Superiority Trial to Compare the Effectiveness of a Mental Health Specialist VIDEo Consultations Model Versus Treatment as Usual in Patients With Depression or Anxiety Disorders in Primary Care
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 24, 2020 (Actual)
Primary Completion Date
May 24, 2022 (Actual)
Study Completion Date
November 18, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Heidelberg University
Collaborators
Heinrich-Heine University, Duesseldorf

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Even in Western health care systems, most people with mental disorders, including those with severe and chronic disorders, are treated solely by their general practitioner (GP). Notably, the accessibility of mental health specialist care is mainly complicated by (a) long waiting times for specialists, (b) long travel distances to specialists, particularly in rural and remote areas, (c) patients' reservations about mental health specialist care (including fear of being stigmatised by seeking such care). To mitigate those barriers, technology-based integrated care models have been proposed. The purpose of this study is to measure the effectiveness of a mental health specialist video consultations model versus treatment as usual in patients with depression or anxiety disorders in primary care. In an individually randomized, prospective, two-arm superiority study with parallel group design, N = 320 patients with anxiety and/or depressive disorder will be recruited in GP practices.
Detailed Description
The purpose of this study is to measure the effectiveness of a mental health specialist video consultations model versus treatment as usual in patients with depression or anxiety disorders in primary care. In total, the investigators plan to enrol 320 patients who will be randomly allocated to the experimental condition (mental health specialist video consultations) or the control condition (treatment as usual from their GP) in a 1:1 ratio. General practitioners will recruit patients during their regular clinic hours. If the patient is interested in participation, the patient will receive the informed consent form and the baseline questionnaire from the GP. The practice team will send the patient's contact details to the study team who will screen the patient with respect to the eligibility criteria. Patients will be randomly allocated to one of the two study conditions (video consultation model vs. treatment-as-usual, TAU) in a 1:1 ratio by central randomisation. The evaluation of the primary outcome will be performed according to the intention-to-treat principle. The health economic evaluation will be carried out from the perspective of society. A cost-effectiveness and a cost-utility analysis will be carried out.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety Disorder
Keywords
primary care, mental health, telemedicine, video consultations, effectiveness, health services research

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
376 (Actual)

8. Arms, Groups, and Interventions

Arm Title
mental health specialist video consultation
Arm Type
Experimental
Arm Description
The intervention group will receive five video consultations with psychotherapists directly in the GP's practice. The consultations will be carried out via the web portal of a certified video service provider (arztkonsultation ak GmbH). The patient will be located in the GP's practice and the psychotherapist in his practice or another suitable room. Patients are scheduled for five sessions of 50 minutes.
Arm Title
treatment as usual by the GP
Arm Type
No Intervention
Arm Description
Routine treatment by the GP, which may or may not include conversations about psychosocial problems and/or referral to specialised services (e.g., inpatient therapy, counseling, self-help).
Intervention Type
Behavioral
Intervention Name(s)
mental health specialist video consultation
Intervention Description
The consultations will be based on a psychodynamic understanding with a solution-oriented stance and will follow a manual: Session 1: Getting familiar with the telemental health setting, building a working alliance and deepening diagnostics. Session 2: Clarification of the task/objective, focus building, motivational interviewing if necessary. Session 3-4: Focused brief interventions e.g. psychoeducation, promotion of social resources, activation of health-promoting lifestyles (sleep hygiene, eating diary, relaxation etc.), work on personal problems and, if necessary, initiation of further specialised treatment. Session 5: Ending the intervention, stabilisation, subsequent treatment plan and communicating a case summary to the general practitioner
Primary Outcome Measure Information:
Title
The Patient Health Questionnaire Depression and Anxiety Scale (PHQ-ADS)
Description
composite measure of depression and anxiety (range: 0-48 Points, higher score indicates more severly depressed/anxious)
Time Frame
6 months after inclusion
Secondary Outcome Measure Information:
Title
The Patient Health Questionnaire Depression and Anxiety Scale (PHQ-ADS)
Description
composite measure of depression and anxiety (range: 0-48 Points, higher score indicates more severly depressed/anxious)
Time Frame
12 months after inclusion
Title
The Patient Health Questionnaire (PHQ-9)
Description
depressive symptom severity (range: 0-27 Points, higher score indicates more severly depressed)
Time Frame
6 months after inclusion, 12 months after inclusion
Title
Generalized Anxiety Disorder Scale (GAD-7)
Description
anxiety symptom severity, range: 0-21, higher score indicates worse outcome
Time Frame
6 months after inclusion, 12 months after inclusion
Title
Short-Form Health Survey 12 (SF-12)
Description
health related quality of life (two dimensions: physical and mental quality of life, ranges: 0-100, higher score indicates higher quality of life
Time Frame
6 months after inclusion, 12 months after inclusion
Title
Recovery Assessment Scale (RAS-G)
Description
self-reported mental health recovery, five dimension: 1) Goal and success orientation, 2) No domination by Symptoms, 3) Personal confidence and hope, 4) Reliance on others, 5) Willingness to ask others for help, ranges 1-5, higher score indicates better outcome
Time Frame
6 months after inclusion, 12 months after inclusion
Title
Somatic Symptom Disorder-B Criteria Scale (SSD-12)
Description
self-reported somatisation, range: 0-48, higher score indicates worse outcome
Time Frame
6 months after inclusion, 12 months after inclusion
Title
Patient Assessment of Chronic Illness Care (PACIC)
Description
patients' satisfaction with the care of their chronic disease, range: 1-5, higher score indicates higher satisfaction
Time Frame
6 months after inclusion, 12 months after inclusion
Title
EQ-5D
Description
health related quality of life for health economic Evaluations, 5 dimensions: 1) Mobility, 2) Self-Care, 3) Usual Activities, 4) Pain/Discomfort, 5)Anxiety/Depression
Time Frame
6 months after inclusion, 12 months after inclusion
Title
Questionnaire for the Assessment of Medical and non Medical Resource Utilisation in Mental Disorders (FIMPsy)
Description
self reported use of medical and psychosocial services for health-economic evaluation
Time Frame
6 months after inclusion, 12 months after inclusion
Other Pre-specified Outcome Measures:
Title
Assessment of Negative Effects of Psychotherapy (INEP)
Description
unintended/adverse effects of the intervention
Time Frame
6 months after inclusion, 12 months after inclusion (not measured at baseline, patients in control condition fill in adapted version)
Title
Normalisation MeAsure Development questionnaire (NoMAD)
Description
measurement of acceptance of newly introduced treatment models, 4 dimensions, range:1-5, lower score indicates greater acceptance of the intervention
Time Frame
6 months after inclusion, 12 months after inclusion (measured in GPs and study therapists only)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: at least one of the following psychological conditions i) at least moderately severe depression, defined as a PHQ-9 score of 10 or greater with either item one and/or two being endorsed, ii) at least moderately general anxiety disorder, defined as a Generalized Anxiety Disorder (GAD)-7 score of 10 or greater, or iii) exceeding the cut off of 11 points of the combined anxiety and depression score (PHQ-ADS) currently no or as yet insufficient treatment (psychotherapy, psychopharmacotherapy, or both) or difficulty with adherence capable of giving consent written informed consent Exclusion Criteria: substance abuse/dependence that is likely to compromise intervention adherence risk of endangerment to others and/or risk of self-endangerment need for emergency medical treatment acute psychotic symptoms severe cognitive impairment or dementia significant hearing and/or visual impairment pregnancy in the ≥ 2nd Trimester prior experience with video consultations as part of the feasibility trial insufficient German language proficiency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Markus W Haun, MD, MSc
Organizational Affiliation
Department of General Internal Medicine and Psychosomatics, Heidelberg University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Heidelberg University
City
Heidelberg
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
D-69120
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
33952313
Citation
Haun MW, Tonnies J, Krisam R, Kronsteiner D, Wensing M, Szecsenyi J, Vomhof M, Icks A, Wild B, Hartmann M, Friederich HC. Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial). Trials. 2021 May 5;22(1):327. doi: 10.1186/s13063-021-05289-3.
Results Reference
derived

Learn more about this trial

Mental Health Specialist Video Consultations for Primary Care Patients

We'll reach out to this number within 24 hrs